Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL819920 | 0.80 | MAPT (0.48) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL3955936 | 0.78 | ALDH1A1 (0.34) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL427816 | 0.78 | RAB9A (0.77) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL18118972 | 0.78 | RAB9A (0.77) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL127279 | 0.78 | RAB9A (0.77) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL4882852 | 0.78 | MAPT (0.56) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL1679451 | 0.77 | GABRA1 (0.44) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL204711 | 0.77 | CA1 (0.47) | ALDH1A1CA1CA2CA9TSHR | |
| SCHEMBL503302 | 0.77 | SLC6A2 (0.37) | MAPTRAB9AALDH1A1MAPK1NPC1 | |
| SCHEMBL424728 | 0.76 | TSHR (0.73) | MAPTRAB9AALDH1A1MAPK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4263677-B1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL INT RESEARCH (NL) | 2024-10-30 | — | — | EP | claimed |
| EP-4263676-B1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL INT RESEARCH (NL) | 2024-10-30 | — | — | EP | claimed |
| US-20240025871-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL USA, INC. | 2024-01-25 | — | — | US | claimed |
| EP-4263677-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | Shell Internationale Research Maatschappij B.V. (NL) | 2023-10-25 | — | — | EP | claimed |
| EP-4263676-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | Shell Internationale Research Maatschappij B.V. (NL) | 2023-10-25 | — | — | EP | claimed |
| CN-115181381-A | Hydrogel for preserving cells at low temperature and monitoring ROS content in real time, preparation and application thereof | 天津大学 | 2022-10-14 | — | — | CN | claimed |
| WO-2022133271-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL OIL COMPANY (US) | 2022-06-23 | — | — | WO | claimed |
| WO-2022133243-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL OIL COMPANY (US) | 2022-06-23 | — | — | WO | claimed |
| US-20220194914-A1 | METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL | SHELL OIL COMPANY | 2022-06-23 | — | — | US | claimed |
| CN-110483291-B | Synthesis method of (E) -beta-aryl-beta, gamma-unsaturated ester compound | 安阳师范学院 | 2021-09-10 | — | — | CN | claimed |
| CN-110523354-B | Preparation method of microreactor containing immobilized catalyst | 浙江大学 | 2021-01-19 | — | — | CN | claimed |
| CN-110105255-B | Mild synthesis method of diaryl thioether | 江西理工大学 | 2020-11-03 | — | — | CN | claimed |
| CN-111529750-A | Bionic skin capable of monitoring and promoting wound healing in real time and preparation method and application thereof | 天津大学 | 2020-08-14 | — | — | CN | claimed |
| CN-111303150-A | High-efficiency narrow-half-peak-width aggregation state luminescent material | 苏州大学 | 2020-06-19 | — | — | CN | claimed |
| CN-111253234-A | Method for synthesizing biphenyl compounds by taking suaeda salsa extract liquid as solvent | 遵义医科大学 | 2020-06-09 | — | — | CN | claimed |
| WO-2026102327-A1 | METHODS FOR COVALENTLY FUNCTIONALIZING SEMICONDUCTING SINGLE WALLED CARBON NANOTUBES AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260052832-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2026-02-19 | — | — | US | disclosed |
| EP-0199260-B1 | BORONIC ACID ADDUCTS OF TECHNETIUM-99M DIOXIME COMPLEXES | E.R. Squibb & Sons, Inc. (US) | 1989-12-06 | — | — | EP | disclosed |
| US-4705849-A | Boronic acid adducts of technetium-99m dioxime complexes | E. R. SQUIBB & SONS, INC. (US) | 1987-11-10 | — | — | US | disclosed |
| EP-0199260-A2 | Boronic acid adducts of technetium-99M dioxime complexes | E.R. Squibb & Sons, Inc. (US) | 1986-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260052832-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | ETV1, L1CAM, CCNT1 | MAPT 2214/4885RAB9A 2082/4885ALDH1A1 994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.